A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Part of paid clinical trials in Canoga Park, California.
- Sponsor
- Pfizer
- Study ID
- NCT07013474
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- COVID-19 Infection
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ibuzatrelvir — DRUGtablet
- remdesivir — DRUGinjection, for intravenous use
- placebo for ibuzatrelvir — DRUGtablet
- placebo for remdesivir — DRUGinjection, for intravenous use
Study Details
This is a Phase 3, randomized, actively controlled, double-blinded, double-dummy, superiority study to evaluate the efficacy and safety of ibuzatrelvir alone and in combination with remdesivir IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who are non-hospitalized or are hospitalized at baseline with mild-to-moderate COVID-19.
Key Dates
- First listed
- Jun 10, 2025
- Start date
- Jul 14, 2025
- Status verified
- Aug 2026
- Primary completion
- Sep 27, 2027
- Completion
- Feb 25, 2028
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Ibuzatrelvir + RemdesivirParticipants will receive ibuzatrelvir orally twice a day + IV remdesivir
- Experimental: IbuzatrelvirParticipants will receive ibuzatrelvir orally twice a day + IV placebo for remdesivir
- Experimental: RemdesivirParticipants will receive placebo for ibuzatrelvir orally twice a day + IV remdesivir
Primary Outcome Measure
The difference in the proportion of patients meeting the primary composite endpoint, between ibuzatrelvir and remdesivir vs remdesivir groups in symptomatic adult participants with COVID-19 who are severely immunocompromised [ Time Frame: 38 days ]
Central Contacts
- Pfizer CT.gov Call Center1-800-718-1021
Locations (66)
Find similar trials in Canoga Park, CA
By research site
Hope Clinical Research, Inc.· Canoga Park, CAAmicis Research Center - Granada Hills· Granada Hills, CAJacobs Medical Center at UC San Diego Health· La Jolla, CAUC Davis CTSC Clinical Research Center· Sacramento, CAUniversity of California Davis Health· Sacramento, CAUC San Diego Medical Center - Hillcrest· San Diego, CA
Related Studies
- Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast SurgeryRecruiting · M.D. Anderson Cancer Center · Conroe, Texas
- Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 PandemicRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center WorkforceRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Clazakizumab vs. Placebo - COVID-19 InfectionPHASE2 · Recruiting · The Methodist Hospital Research Institute · Houston, Texas